bf/NYSE:GMED_icon.jpeg

NYSE:GMED

Globus Medical, Inc.

  • Stock

USD

Last Close

63.95

17/05 20:00

Market Cap

7.41B

Beta: 1.06

Volume Today

711.40K

Avg: 1.89M

PE Ratio

37.35

PFCF: 71.50

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
66.33M
-
80.65M
21.59%
98.10M
21.64%
108.98M
11.08%
110.55M
1.44%
119.83M
8.40%
163.78M
36.68%
212.73M
29.89%
233.08M
9.56%
267.99M
14.98%
573.56M
114.02%
average payables
12.64M
-
17.00M
34.48%
18.62M
9.54%
16.72M
10.18%
21.26M
27.11%
25.47M
19.81%
25.25M
0.83%
21.41M
15.23%
20.08M
6.21%
29.03M
44.56%
46.39M
59.80%
average receivables
61.87M
-
73.17M
18.27%
83.78M
14.50%
91.07M
8.70%
111.42M
22.35%
135.71M
21.80%
153.39M
13.03%
155.26M
1.22%
156.88M
1.04%
191.48M
22.06%
361.09M
88.58%
book value per share
5.10
-
6.21
21.86%
7.53
21.13%
8.70
15.59%
10.06
15.59%
12.11
20.45%
14.14
16.79%
15.28
8.03%
17.29
13.14%
18.38
6.31%
34.88
89.78%
capex per share
-0.26
-
-0.26
2.78%
-0.53
103.29%
-0.43
19.91%
-0.53
24.63%
-0.61
14.41%
-0.71
17.00%
-0.65
9.50%
-0.56
12.53%
-0.74
30.48%
-0.68
7.35%
capex to depreciation
-1.22
-
-1.14
6.79%
-2.11
85.22%
-1.06
49.94%
-1.22
15.58%
-1.43
17.58%
-1.34
6.44%
-1.01
24.53%
-0.81
19.57%
-1.08
33.22%
-0.54
50.15%
capex to operating cash flow
-0.25
-
-0.31
23.42%
-0.42
33.12%
-0.24
42.82%
-0.32
35.12%
-0.33
2.20%
-0.41
25.18%
-0.32
22.16%
-0.21
35.69%
-0.41
101.46%
-0.32
22.52%
capex to revenue
-0.05
-
-0.05
4.26%
-0.09
78.56%
-0.07
22.16%
-0.08
11.21%
-0.08
3.80%
-0.09
7.59%
-0.08
10.44%
-0.06
26.39%
-0.07
21.90%
-0.05
31.06%
cash per share
2.58
-
2.43
5.88%
2.96
21.82%
3.04
2.65%
3.88
27.93%
3.47
10.63%
3.14
9.47%
4.33
37.79%
4.40
1.69%
4.44
0.85%
4.52
1.74%
days of inventory on hand
255.90
-
299.44
17.01%
289.30
3.39%
305.35
5.55%
263.00
13.87%
300.53
14.27%
398.14
32.48%
384.62
3.39%
361.61
5.98%
413.79
14.43%
564.73
36.48%
days payables outstanding
46.30
-
70.01
51.20%
43.90
37.30%
47.34
7.85%
60.74
28.31%
59.29
2.39%
49.92
15.81%
30.56
38.79%
33.50
9.63%
49.96
49.15%
37.73
24.48%
days sales outstanding
54.72
-
62.48
14.17%
57.86
7.40%
61.99
7.14%
72.92
17.64%
73.90
1.34%
75.49
2.14%
68.51
9.24%
63.11
7.89%
77.55
22.88%
117.49
51.51%
debt to assets
0.00
-
0.05
1,305.39%
0.05
8.36%
0.05
8.65%
0.08
-
debt to equity
0.00
-
0.05
1,299.36%
0.06
10.60%
0.05
7.91%
0.11
-
dividend yield
earnings yield
0.04
-
0.04
12.52%
0.04
3.30%
0.04
3.09%
0.03
38.28%
0.04
36.10%
0.03
28.02%
0.02
40.16%
0.02
28.94%
0.03
24.24%
0.02
21.07%
enterprise value
1.78B
-
2.16B
21.23%
2.58B
19.77%
2.24B
13.30%
3.84B
71.26%
4.10B
6.77%
5.64B
37.73%
6.19B
9.71%
7.08B
14.38%
7.31B
3.27%
6.16B
15.72%
enterprise value over ebitda
10.65
-
12.58
18.21%
14.87
18.17%
11.04
25.74%
18.06
63.53%
18.12
0.35%
24.54
35.40%
33.89
38.12%
24.49
27.72%
23.30
4.88%
15.36
34.05%
ev to operating cash flow
19.04
-
27.25
43.13%
21.19
22.25%
13.03
38.49%
24.05
84.52%
22.55
6.22%
32.81
45.47%
31.14
5.09%
25.63
17.70%
40.97
59.86%
25.31
38.23%
ev to sales
4.10
-
4.55
11.03%
4.74
4.29%
3.97
16.26%
6.03
51.87%
5.75
4.76%
7.18
25.03%
7.84
9.20%
7.39
5.81%
7.15
3.27%
3.93
45.04%
free cash flow per share
0.75
-
0.58
23.33%
0.75
29.71%
1.37
82.82%
1.12
17.88%
1.25
10.78%
1.02
18.05%
1.37
34.27%
2.18
58.87%
1.04
52.28%
1.44
38.68%
free cash flow yield
0.04
-
0.02
34.91%
0.03
10.82%
0.06
105.00%
0.03
50.43%
0.03
5.20%
0.02
39.76%
0.02
21.22%
0.03
43.51%
0.01
53.61%
0.03
93.28%
graham net net
2.47
-
2.30
6.84%
2.94
27.77%
3.38
14.75%
4.29
26.94%
4.07
5.03%
4.05
0.43%
4.86
19.94%
4.67
3.95%
5.26
12.73%
2.03
61.48%
graham number
9.22
-
11.71
27.09%
14.18
21.01%
14.61
3.09%
15.89
8.71%
20.87
31.39%
22.32
6.94%
18.89
15.38%
24.00
27.08%
27.98
16.56%
29.00
3.67%
income quality
1.36
-
0.86
37.16%
1.08
26.32%
1.65
52.35%
1.49
9.79%
1.16
21.89%
1.11
4.55%
1.94
75.41%
1.85
4.72%
0.94
49.32%
1.98
111.16%
intangibles to total assets
0.08
-
0.12
47.39%
0.15
20.39%
0.18
20.38%
0.19
3.93%
0.16
13.60%
0.14
16.50%
0.15
7.08%
0.13
12.54%
0.13
0.91%
0.46
268.90%
interest coverage
-171.88
-
-132.07
23.16%
-50.42
61.82%
-24.49
51.43%
-12.75
47.93%
-9.88
22.52%
7.99
180.83%
18.50
131.57%
16.02
13.41%
6.61
58.70%
interest debt per share
-0.01
-
-0.01
60.59%
-0.03
132.96%
-0.07
114.82%
-0.09
30.46%
0.58
744.65%
1.04
80.30%
1.03
1.11%
0.14
86.24%
3.92
2,667.99%
inventory turnover
1.43
-
1.22
14.54%
1.26
3.50%
1.20
5.26%
1.39
16.10%
1.21
12.49%
0.92
24.52%
0.95
3.51%
1.01
6.36%
0.88
12.61%
0.65
26.73%
invested capital
0.00
-
0.05
1,299.36%
0.06
10.60%
0.05
7.91%
0.11
-
market cap
1.87B
-
2.24B
19.80%
2.64B
18.06%
2.37B
10.26%
3.96B
66.69%
4.24B
7.10%
5.84B
37.80%
6.43B
10.13%
7.27B
13.12%
7.46B
2.60%
6.11B
18.13%
net current asset value
322.86M
-
351.93M
9.00%
426.02M
21.05%
418.21M
1.83%
509.62M
21.86%
515.53M
1.16%
557.84M
8.21%
648.58M
16.27%
648.64M
0.01%
753.59M
16.18%
827.25M
9.77%
net debt to ebitda
-0.54
-
-0.48
10.83%
-0.35
27.86%
-0.65
88.87%
-0.56
14.46%
-0.62
10.54%
-0.85
37.69%
-1.31
53.99%
-0.67
49.04%
-0.48
28.22%
0.13
127.62%
net income per share
0.74
-
0.98
32.53%
1.19
20.90%
1.09
8.07%
1.12
2.24%
1.60
43.32%
1.57
2.07%
1.04
33.72%
1.48
42.74%
1.89
27.80%
1.07
43.37%
operating cash flow per share
1.01
-
0.84
16.72%
1.28
52.71%
1.80
40.06%
1.66
7.76%
1.86
11.95%
1.73
6.53%
2.02
16.26%
2.74
36.00%
1.78
35.23%
2.12
19.58%
payables turnover
7.88
-
5.21
33.86%
8.32
59.49%
7.71
7.28%
6.01
22.06%
6.16
2.45%
7.31
18.78%
11.95
63.37%
10.90
8.78%
7.31
32.96%
9.67
32.41%
receivables turnover
6.67
-
5.84
12.41%
6.31
7.99%
5.89
6.66%
5.01
14.99%
4.94
1.33%
4.84
2.10%
5.33
10.18%
5.78
8.56%
4.71
18.62%
3.11
34.00%
research and ddevelopement to revenue
0.06
-
0.07
8.01%
0.07
1.63%
0.08
16.31%
0.07
13.02%
0.08
13.33%
0.08
1.73%
0.11
40.04%
0.10
5.15%
0.07
29.74%
0.08
10.76%
return on tangible assets
0.13
-
0.15
13.47%
0.16
5.94%
0.14
13.71%
0.12
10.74%
0.14
17.18%
0.12
18.40%
0.07
39.21%
0.09
22.55%
0.10
20.01%
0.05
56.99%
revenue per share
4.69
-
5.03
7.36%
5.73
13.85%
5.90
2.88%
6.61
12.06%
7.28
10.23%
7.92
8.75%
8.00
1.05%
9.51
18.83%
10.18
7.04%
13.68
34.40%
roe
0.15
-
0.16
8.76%
0.16
0.19%
0.13
20.47%
0.11
11.54%
0.13
18.99%
0.11
16.15%
0.07
38.64%
0.09
26.17%
0.10
20.22%
0.03
70.16%
roic
0.14
-
0.16
8.89%
0.16
0.33%
0.12
21.79%
0.11
14.04%
0.12
11.74%
0.10
19.40%
0.06
40.34%
0.08
36.47%
0.10
24.72%
0.02
77.34%
sales general and administrative to revenue
0.42
-
0.40
5.76%
0.39
0.76%
0.39
0.26%
0.42
6.91%
0.44
3.78%
shareholders equity per share
5.10
-
6.21
21.86%
7.53
21.13%
8.70
15.59%
10.06
15.59%
12.11
20.45%
14.14
16.79%
15.28
8.03%
17.29
13.14%
18.38
6.31%
34.88
89.78%
stock based compensation to revenue
0.01
-
0.01
25.80%
0.02
18.04%
0.02
14.05%
0.02
14.42%
0.03
33.01%
0.03
8.13%
0.03
3.30%
0.03
6.96%
0.03
0.48%
0.03
4.83%
tangible asset value
424.45M
-
497.73M
17.26%
590.12M
18.56%
664.45M
12.60%
765.23M
15.17%
974.46M
27.34%
1.19B
22.62%
1.26B
5.67%
1.49B
18.25%
1.59B
6.18%
1.64B
3.37%
tangible book value per share
4.58
-
5.28
15.30%
6.21
17.54%
6.95
11.89%
7.95
14.45%
9.96
25.21%
12.05
21.05%
12.81
6.28%
14.82
15.72%
15.78
6.46%
14.30
9.40%
working capital
348.87M
-
380.61M
9.10%
462.11M
21.41%
433.87M
6.11%
527.27M
21.53%
534.56M
1.38%
576.07M
7.76%
700.97M
21.68%
724.35M
3.34%
824.14M
13.78%
1.52B
84.80%

All numbers in USD (except ratios and percentages)